US Patent Issued to Soricimed Biopharma on March 4 for "TRPV3 agonists for the treatment of skin conditions" (Canadian Inventor)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,239,729, issued on March 4, was assigned to Soricimed Biopharma Inc. (Moncton, Canada).

"TRPV3 agonists for the treatment of skin conditions" was invented by John M. Stewart (Ottawa).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described are methods and uses of TRPV3 agonists for the treatment of conditions associated with TRPV3 pathophysiology such as acne, psoriasis, dermatitis, would healing, the inhibition of hair growth, anxiety or depression. Peptides comprising all or part of the C-terminal portion of soricidin are shown to activate TRPV3 cation channel activity and/or promote wound healing in keratinocytes."

The patent was filed on Dec. 11, 20...